Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Laboratory Evaluation and Diagnosis of Thalassemia

Norafiza Mohd Yasin

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Severe Anemia: Indications for Blood Transfusion, Initial Work Up, a…

APP2APP Virtual Lectures, Inc

D. Thomas

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Causes and Classification of Normocytic Normochromic Anemia

The Blood Project

W. Aird

Treatment of Thalassemia From Transplant to Novel Agents

Nita Radhakrishnan

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber